Phase 2 study of everolimus monotherapy in patients with nonfunctioning neuroendocrine tumors or pheochromocytomas/paragangliomas-Reference-Cited by-同舟云学术

Phase 2 study of everolimus monotherapy in patients with nonfunctioning neuroendocrine tumors or pheochromocytomas/paragangliomas

Published:2012-06-26 Issue:24 Volume:118 Page:6162-6170
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Oh Do-Youn,Kim Tae-Won,Park Young Suk,Shin Sang Joon,Shin Seong Hoon,Song Eun-Kee,Lee Hyo Jin,Lee Kewn-wook,Bang Yung-Jue

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/cncr.27675/fullpdf

Reference28 articles.

1. One hundred years after “carcinoid”: epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States;Yao;J Clin Oncol.,2008

2. Neuroendocrine tumor epidemiology: contrasting Norway and North America;Hauso;Cancer.,2008

3. A three-decade analysis of 3,911 small intestinal neuroendocrine tumors: the rapid pace of no progress;Modlin;Am J Gastroenterol.,2007

4. Clinical course of neuroendocrine tumors with different origins (the pancreas, gastrointestinal tract, and lung) [published online ahead of print June 8, 2011];Kim;Am J Clin Oncol.

5. Biological characteristics and treatment outcomes of metastatic or recurrent neuroendocrine tumors: tumor grade and metastatic site are important for treatment strategy;Kim;BMC Cancer.,2010

Cited by 85 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Management of metastatic pheochromocytomas and paragangliomas: when and what;Current Problems in Cancer;2024-08

2. Therapeutic Strategy for Functional Metastatic Malignant Paraganglioma: A Case Report and Review of the Literature;Cureus;2024-05-10

3. The Management of Phaeochromocytomas and Paragangliomas in the Era of Precision Medicine: Where Are We Now? Evidence-Based Systemic Treatment Options and Future Cluster Oriented Perspectives;Pharmaceuticals;2024-03-08

4. Molecular classification and tumor microenvironment characteristics in pheochromocytomas;eLife;2024-02-26

5. ScRNA-seq of Diverse Pheochromocytoma Patients Reveals Distinct Microenvironment Characteristics and Supports an Informative Molecular Classification System;2024-02-14